Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

December 31, 2009

Conditions
Fungal Infection by Site
Interventions
DRUG

Fluconazole

Patients hospitalized with severe infection caused by C. albicans, documented by standard clinical signs, symptoms, and radiology, and having failed at least four days of fluconazole therapy

Trial Locations (1)

14226

CPL Associates,LLC, Buffalo

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

CPL Associates

OTHER

NCT00721487 - Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections | Biotech Hunter | Biotech Hunter